Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Research links protein to breast-cancer migration

13.06.2006
Scientists have moved a step closer to understanding how breast cancer spreads to other parts of the body, thanks to research published this week.

The University of Manchester team has discovered a protein potentially involved in the spread or ‘metastatic progression’ of tumours.

The researchers believe their findings could lead to new approaches to treating breast cancer as blocking the protein’s actions has the potential to stop cancerous cells migrating.

“What we have identified is a new role for a protein called LPP,” explained Professor Andrew Sharrocks, who headed the research team.

“Until now, this protein was only thought to function at the cell periphery but we have shown that it works in conjunction with another protein – PEA3 – in the cell nucleus.

“PEA3 has already been implicated in the spread of breast cancer but we have found that the LPP molecule is essential for the correct function of PEA3.”

“If we can target the LPP protein and stop it from working in cancerous cells, we have a possible new route to therapy.”

The research, published in the scientific journal Molecular and Cellular Biology, may have implications for other cancer systems.

“Benign tumours remain in one part of the body and are relatively easy to treat through surgery,” said Professor Sharrocks, who is based in the University’s Faculty of Life Sciences.

“But metastases – malignant cancers that spread to other parts of the body – can be much more problematic.

“Our research is potentially fundamental to all types of cancers and has the potential to offer alternative therapies to stop cancers spreading to other organs in the body.”

News of the scientific breakthrough comes as the University announced Breast Cancer Campaign funding for two other research projects worth nearly £300,000.

Dr Andrew Gilmore, also in the Faculty of Life Sciences, has been awarded a grant of £146,000 to examine in more detail a process called ‘anoikis’.

Anoikis is the process whereby the body ambushes and kills roving cells that have gone ‘AWOL’ and are moving around the body without permission – like breast-cancer cells that spread from the breast to form tumours in other parts of the body.

Current breast-cancer treatments have been designed to kick start the anoikis process and kill these rogue cells. But the cancer cells are clever and learn how to avoid being destroyed, which means these treatments no longer work and patients often see their breast cancer return.

Dr Gilmore said: “Understanding more about how the body’s natural defences work and why breast-cancer cells can avoid them will help develop new drugs that can kill invasive cells that have become resistant to standard treatment.”

A further £143,000 has been awarded by the charity to Dr Keith Brennan, again in Life Sciences, to uncover how a group of proteins called Notch are able to protect breast-cancer cells from dying.

“Notch proteins appear to shield breast-cancer cells from the body’s natural defences and also from being destroyed by chemotherapy,” said Dr Brennan.

“This research will help to uncover exactly how Notch proteins have this effect and whether inhibiting their action may be one way of making chemotherapy treatments more effective.”

Pamela Goldberg, Chief Executive of Breast Cancer Campaign, added: “The spread of breast-cancer cells to other areas of the body is the single most important factor in breast-cancer mortality.

“When breast-cancer cells become invasive they become less responsive to treatment and the disease becomes more difficult for a clinician to manage.

“Both these studies could help to develop new drugs which kill breast-cancer cells before they have an opportunity to spread.”

Aeron Haworth | alfa
Further information:
http://www.manchester.ac.uk

More articles from Life Sciences:

nachricht A Map of the Cell’s Power Station
18.08.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau

nachricht On the way to developing a new active ingredient against chronic infections
21.08.2017 | Deutsches Zentrum für Infektionsforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

New bioimaging technique is fast and economical

21.08.2017 | Medical Engineering

Silk could improve sensitivity, flexibility of wearable body sensors

21.08.2017 | Materials Sciences

On the way to developing a new active ingredient against chronic infections

21.08.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>